UNSPSC 51123900: Antiarrythmic indoles

This classification denotes substances derived from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, substances called indoles, that prevent or treat irregular heartbeat, disturbances of normal rhythmic heart beating, or normal operation of myocardial contraction, thus the term ANTIARRYTHMIC INDOLES.

UNSPSC 51123900 Antiarrhythmic indoles, a Class code, covers emergency cardiac medications and antiarrhythmic agents that state and local emergency services and health agencies procure for life support and acute-care settings. State and local governments buy these drugs through direct government purchase orders, cooperative purchasing agreements, and pharmacy benefit programs that supply hospitals, fire rescue departments, emergency medical services, and state health agencies. The scope spans individual medication units (vials, injections) procured in specific quantities with firm expiration-date requirements and rapid delivery cycles, as well as broader generic pharmaceutical supply agreements administered through multistate cooperative purchasing vehicles that aggregate demand across state facilities and member jurisdictions.

Issuing bodies include city fire and rescue departments (Tampa Fire Rescue), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across member jurisdictions including Oregon). Recent solicitation activity shows a Tampa Fire Rescue procurement through the City of Tampa Purchasing Department (IFB 26P00188, due April 8, 2026) for four specific antiarrhythmic and cardiac-support medications—Labetalol HCI, Epinephrine, Adenosine, and Diltiazem—totaling 3,530 units with a $40,000 estimated contract value and a one-year term with renewal options; a Texas HHS Commission RFI posted April 3, 2026, exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler channels; and a Minnesota Department of Administration cooperative purchasing RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) with a July 1, 2026 effective date and two-year initial term. Primary activity concentrates in Florida (Tampa), Texas, and Minnesota, with the MMCAP agreement extending to Oregon and other participating jurisdictions. Vendors supplying this code face firm pricing, comprehensive insurance requirements ($5 million general liability, $2 million network security liability), FDA compliance, cGMP certification, and Drug Supply Chain Security Act compliance.